Last reviewed · How we verify
Prednisone, ciclosporin and mycophenolate mofetil
Prednisone, ciclosporin and mycophenolate mofetil is a Small molecule drug developed by Beijing Friendship Hospital. It is currently FDA-approved.
Prednisone, ciclosporin, and mycophenolate mofetil are marketed drugs developed by Beijing Friendship Hospital, with a key composition patent expiring in 2028. The primary strength of these drugs lies in their established market presence and broad therapeutic applications. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | Prednisone, ciclosporin and mycophenolate mofetil |
|---|---|
| Sponsor | Beijing Friendship Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Tocilizumab in Cardiac Transplantation (PHASE2)
- Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia (PHASE1)
- Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL (PHASE2, PHASE3)
- Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation (PHASE4)
- Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients (NA)
- Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients
- Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma (PHASE2)
- Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prednisone, ciclosporin and mycophenolate mofetil CI brief — competitive landscape report
- Prednisone, ciclosporin and mycophenolate mofetil updates RSS · CI watch RSS
- Beijing Friendship Hospital portfolio CI